Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant treatment of esophagus-cardia cancer: comparison of chemotherapy vs chemoradiotherapy before curative resection
2006-001785-16Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin and fluorouracil in esophageal cancer and gastric cardia cancer (GEJ) (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Complete histological response. Started Apr 2006; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
esophageal cancergastric cardia cancer (GEJ)
Beyond the preview
Go deeper on 2006-001785-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001785-16.